Predicting H5N1 disease severity based on T cell responses

New research led by scientists at La Jolla Institute for Immunology (LJI) suggests that many people already have immune cells on “stand by” to fight the H5N1 virus, also known as highly pathogenic avian influenza.

Genome-wide study finds link between CHD1L gene and HIV control

“We searched for human genetic variation that associates with spontaneous control of HIV and identified a novel region in the genome that is only variable

August 3, 2023

Discovery of gene variant could transform treatment for newborn jaundice

One in eight newborn babies has a gene variant that almost completely protects against jaundice. The research, conducted at the University of Gothenburg in Sweden,

September 17, 2024

Leaving FDA, Califf is unapologetic — and warns of staff departures

In a wide-ranging interview, Robert Califf, the departing commissioner of the Food and Drug Administration, defended the FDA’s record under his leadership, praised the progress

January 8, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.